| Gene Symbol | SLC16A2 (MCT8) |
| Full Name | Solute Carrier Family 16 Member 2 (Monocarboxylate Transporter 8) |
| Aliases | SLC16A2 |
| Chromosome | Xq13.2 |
| Protein Family | transporter |
| Target Class | Transporter |
| Mechanism of Action | Substrate supplementation or transporter modulation |
| Druggability | Low (0.39) |
| Clinical Stage | Phase I |
| Pathways | X chromosome, SLC16 family, thyroid function, Blood-Brain Barrier, Lactate/monocarboxylate transport |
| UniProt ID | P36012 |
| NCBI Gene ID | 6568 |
| Ensembl ID | ENSG00000147100 |
| R271H | Missense |
| L471P | Missense |
| Associated Diseases | ALI, ALS, AMI, ARM, Aging, Allan-Herndon-Dudley syndrome |
| Known Drugs/Compounds | Triiodothyroacetic acid |
| Interactions | SLCO1C1, TH, CANCER, MICRORNAS, MIR-375, CYP2E1 |
| SciDEX Target | View Target Profile (1 clinical trials) |
| SciDEX Hypotheses | Astrocytic Lactate Shuttle Enhancement for Grid Ce |
| KG Connections | 165 knowledge graph edges |
| Databases | GeneCardsHPASTRING |